Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Net Sales	$ 1,942.0	$ 1,869.6	$ 3,831.2	$ 3,700.6
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 553.6	$ 525.5	$ 1,065.9	$ 1,026.3
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 144.0	$ 138.2	$ 286.1	$ 271.6
Research and development	109.4	118.1	217.4	228.5
Selling, general and administrative	737.1	725.8	1,473.2	1,441.8
Restructuring and other cost reduction initiatives	41.5	24.4	165.9	66.3
Acquisition, integration, divestiture and related	5.2	7.9	5.5	9.1
Operating expenses	1,590.8	1,539.9	3,214.0	3,043.6
Operating Profit	351.3	329.6	617.2	656.9
Other income (expense), net	2.0	(1.2)	1.9	6.5
Interest expense, net	(51.1)	(51.6)	(101.8)	(99.8)
Earnings before income taxes	302.2	276.8	517.3	563.6
Provision for income taxes	59.1	66.9	101.4	121.0
Net Earnings	243.1	209.9	415.9	442.6
Less: Net earnings attributable to noncontrolling interest	0.3	0.2	0.7	0.5
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 242.8	$ 209.6	$ 415.2	$ 442.1
Earnings Per Common Share
Basic	$ 1.18	$ 1	$ 2.02	$ 2.12
Diluted	$ 1.18	$ 1	$ 2.01	$ 2.1
Weighted Average Common Shares Outstanding
Basic	205.7	208.6	205.4	209.0
Diluted	206.4	209.9	206.3	210.1